CTRI/2019/01/017326
Not yet recruiting
未知
Short course steroid as add-on drug in treatment of chronic migraine- randomised placebo controlled study.
ational Institute of Mental Health and NeuroSciences0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ational Institute of Mental Health and NeuroSciences
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Chronic migraine patients meeting the criteria according to ICHD\-3 (2013\) on prophylaxis for a period of at least 3months.
Exclusion Criteria
- •\-Medical conditions that increase the risk of steroid administration like\-Diabetes Mellitus (operationally defined as FBS \>140; PPBS \>200mg/dl), Impaired glucose tolerance (postprandial glucose levels of 140 to 199 mg per dL), Impaired fasting glucose (glucose levels of 100 to 125 mg per dL in fasting patients), Active infections, Hypertension( \>140/90mmHg),Chronic co\-morbidities that might be affected by steroids or would make changes in the clinical or biochemical values that would likely unmask the blinding. Diagnosis of secondary headache, Complicated migraine, Beck Depression Inventory (BDI) \>24 (moderate depression)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Rationale for therapy with low dose steroids combined with long-acting beta2-agonists in patients with allergic asthma: redirecting innate immune responses by long-term treatment with high doses of inhaled steroidsEUCTR2007-000097-23-NLGlaxoSmithKline
Recruiting
Not Applicable
Intervention study of steroid ointment therapy for ranularanulaJPRN-UMIN000026751agoya City University Graduate School of Medical Sciences Department of Oral and Maxillofacial Surgery20
Recruiting
Phase 2
A clinical trial of steroid therapy for patients with FCMD caused by a homozygous(hetrozygous) 3kb insertion in FKTN gene.Fukuyama-type congenital muscular dystrophyJPRN-jRCT2031230211Ishigaki Keiko20
Recruiting
Phase 2
A clinical trial of steroid therapy for patients with FCMD caused by a homozygous 3kb insertion in FKTN gene.Fukuyama-type congenital muscular dystrophyJPRN-jRCT2031230210Ishigaki Keiko15
Active, not recruiting
Phase 1
Efficacy of a short course of oral steroids for hospitalised preschool children with viral-induced wheeze; a randomised double-blind placebo-controlled trialPre School Viral WheezeEUCTR2004-005124-40-GBniversity Hospital Leicester R&D700